secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001493152-26-008837
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma issues 77.85M shares to settle $68,723 in debt and fees
-----------------------------------------------------------------------

- Issued 77,849,847 common shares between Feb 4-27, 2026 for $53,474 principal, $4,249 interest, $11,000 fees.
- Shares were issued in unregistered private placement under Section 4(a)(2) with no underwriter or commission.
- Post-issuance outstanding shares total 212,318,424 as of March 3, 2026.
- Implied issuance price of approximately $0.0009 per share, suggesting severe dilution for existing holders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000149315226008837/0001493152-26-008837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000149315226008837/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer